10. Long‐term results (at the end of treatment) for QoL.
| Trial |
time point of measurement (in months) |
Intervention (N analysed) | Intervention post mean score (SD) | Comparator (N analysed) | Comparator post mean score (SD) |
| Scale: FKSI‐DRS (score range 0‐36; higher scores represent better QoL) | |||||
| NCT01108445 | 40 | EVE (N = 33) | 26.6 (6.85) | SUN (N = 47) | 26.6 (6.13) |
| NCT00098657/NCT00083889 | 28.5 | SUN (N = 53) | 29.44 (4.210) | IFN (N = 351) | 29.22 (7.694) |
| NCT00920816 | 24.6 | AXI ( N =72) | 26.556 (5.487) | SOR (N=95) | 26.786 (5.982) |
| Scale: EQ‐5D‐VAS (score range 0‐100; higher scores represent better QoL) | |||||
| NCT00098657/NCT00083889 | 28.5 | SUN (N=54) | 76.85 (16.863) | IFN (N = 352) | 75.44 (25.060) |
| NCT00920816 | 24.6 | AXI (N = 71) | 67.254 (19.495) | SOR (N=94) | 67.048 (22.570) |
| Scale: FACT‐G (score range 0‐108; higher scores represent better QoL) | |||||
| NCT00098657/NCT00083889 | 28.5 | SUN (N = 52) | 84.62 (16.257) | IFN (N = 351) | 79.54 (26.109) |
| Scale: FACIT‐F (score range 0‐52; higher scores represent better QoL) | |||||
| NCT00720941 | 38 | PAZ (N = 2) | 38.5 (13.59) | SUN (N = 2) | 29.5 (0.71) |